329 related articles for article (PubMed ID: 30464687)
1. Current landscape of immunotherapy in the treatment of solid tumours, with future opportunities and challenges.
Nixon NA; Blais N; Ernst S; Kollmannsberger C; Bebb G; Butler M; Smylie M; Verma S
Curr Oncol; 2018 Oct; 25(5):e373-e384. PubMed ID: 30464687
[TBL] [Abstract][Full Text] [Related]
2. Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy.
Pan C; Liu H; Robins E; Song W; Liu D; Li Z; Zheng L
J Hematol Oncol; 2020 Apr; 13(1):29. PubMed ID: 32245497
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of the clinical immuno-oncology landscape.
Tang J; Shalabi A; Hubbard-Lucey VM
Ann Oncol; 2018 Jan; 29(1):84-91. PubMed ID: 29228097
[TBL] [Abstract][Full Text] [Related]
4. Molecular Biomarkers of Primary and Acquired Resistance to T-Cell-Mediated Immunotherapy in Cancer: Landscape, Clinical Implications, and Future Directions.
Chae YK; Oh MS; Giles FJ
Oncologist; 2018 Apr; 23(4):410-421. PubMed ID: 29242279
[TBL] [Abstract][Full Text] [Related]
5. Update of early phase clinical trials in cancer immunotherapy.
Lee DH
BMB Rep; 2021 Jan; 54(1):70-88. PubMed ID: 33407992
[TBL] [Abstract][Full Text] [Related]
6. Current State of Combination of Locoregional Therapies with Immune Checkpoint Inhibition.
Restrepo CR; Field DH; Kim AY
J Vasc Interv Radiol; 2020 Nov; 31(11):1740-1744.e9. PubMed ID: 33019993
[TBL] [Abstract][Full Text] [Related]
7. Overview of ongoing clinical trials investigating combined radiotherapy and immunotherapy.
Cushman TR; Caetano MS; Welsh JW; Verma V
Immunotherapy; 2018 Aug; 10(10):851-0. PubMed ID: 30073899
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality-of-life assessment of patients with solid tumors on immuno-oncology therapies.
Voon PJ; Cella D; Hansen AR
Cancer; 2021 May; 127(9):1360-1368. PubMed ID: 33662145
[TBL] [Abstract][Full Text] [Related]
9. Immuno-Oncology in China.
Lu S; Chabner BA
Oncologist; 2019 Feb; 24(Suppl 1):S1-S2. PubMed ID: 30819825
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic Modulation of Human Immunity in the Era of Immuno-oncology: Something Old, Something New.
Bangalore Kumar A; Maus R; Markovic SN
Mayo Clin Proc; 2018 Jul; 93(7):917-936. PubMed ID: 29887221
[TBL] [Abstract][Full Text] [Related]
11. Recruiting Immunity for the Fight against Colorectal Cancer: Current Status and Challenges.
Al-Hujaily EM; Al-Sowayan BS; Alyousef Z; Uddin S; Alammari F
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430176
[TBL] [Abstract][Full Text] [Related]
12. The Future of Cancer Diagnosis, Treatment and Surveillance: A Systemic Review on Immunotherapy and Immuno-PET Radiotracers.
Liberini V; Laudicella R; Capozza M; Huellner MW; Burger IA; Baldari S; Terreno E; Deandreis D
Molecules; 2021 Apr; 26(8):. PubMed ID: 33920423
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy in Metastatic Castration-Resistant Prostate Cancer: Past and Future Strategies for Optimization.
Reimers MA; Slane KE; Pachynski RK
Curr Urol Rep; 2019 Sep; 20(10):64. PubMed ID: 31482315
[TBL] [Abstract][Full Text] [Related]
14. Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation.
Masucci GV; Cesano A; Hawtin R; Janetzki S; Zhang J; Kirsch I; Dobbin KK; Alvarez J; Robbins PB; Selvan SR; Streicher HZ; Butterfield LH; Thurin M
J Immunother Cancer; 2016; 4():76. PubMed ID: 27895917
[TBL] [Abstract][Full Text] [Related]
15. Cancer Nanomedicine: Lessons for Immuno-Oncology.
Sengupta S
Trends Cancer; 2017 Aug; 3(8):551-560. PubMed ID: 28780932
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy and Combination Strategies in Pancreatic Cancer: Current Status and Emerging Trends.
Cheung PF; Lutz M; Siveke JT
Oncol Res Treat; 2018; 41(5):286-290. PubMed ID: 29705789
[TBL] [Abstract][Full Text] [Related]
17. The importance for immunoregulation for long-term cancer control.
Fusi A; Dalgleish A
Future Oncol; 2017 Aug; 13(18):1619-1632. PubMed ID: 28776411
[TBL] [Abstract][Full Text] [Related]
18. Refining Immuno-Oncology Approaches in Metastatic Prostate Cancer: Transcending Current Limitations.
Wong RL; Yu EY
Curr Treat Options Oncol; 2021 Jan; 22(2):13. PubMed ID: 33433743
[TBL] [Abstract][Full Text] [Related]
19. Current approaches to immunotherapy in noncolorectal gastrointestinal malignancies.
Jesus VHF; Felismino TC; Barros E Silva MJ; Souza E Silva V; Riechelmann RP
Clinics (Sao Paulo); 2018 Oct; 73(suppl 1):e510s. PubMed ID: 30365605
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy for Non-melanoma Skin Cancer.
Shalhout SZ; Emerick KS; Kaufman HL; Miller DM
Curr Oncol Rep; 2021 Aug; 23(11):125. PubMed ID: 34448958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
